Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Faris Al-Khalili"'
Autor:
Tove Fredriksson, Katrin Kemp Gudmundsdottir, Viveka Frykman, Leif Friberg, Faris Al-Khalili, Johan Engdahl, Emma Svennberg
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Short supraventricular tachycardias with atrial fibrillation (AF) characteristics are associated with an increased risk of developing AF over time. The aim of this study is to determine if presence of very short-lasting episodes o
Externí odkaz:
https://doaj.org/article/f64ef90515f94467825bd6c9def47f77
Autor:
Viveka Frykman, Faris Al-Khalili, Katrin Kemp-Gudmundsdottir, Emma Svennberg, Tove Fredriksson, Leif Friberg, Mårten Rosenqvist, Johan Engdahl
Publikováno v:
Open Heart, Vol 7, Iss 1 (2020)
BackgroundHigh plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) indicate increased probability of congestive heart failure (CHF) and atrial fibrillation (AF) and are associated with poor prognosis.ObjectiveWe aimed to describe t
Externí odkaz:
https://doaj.org/article/9d6bcaef933b4e56ada5ca922939cb50
Publikováno v:
PLoS Medicine, Vol 17, Iss 3, p e1003063 (2020)
BackgroundThe European Society of Cardiology guidelines recommend (Class IA) single-time-point screening for atrial fibrillation (AF) using pulse palpation. The role of pulse palpation for AF detection has not been validated against electrocardiogram
Externí odkaz:
https://doaj.org/article/4114c593b98947b6b643be197698c61d
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212974 (2019)
BackgroundAtrial fibrillation (AF), an important cause of thromboembolic events, is often silent and intermittent, thus presenting a diagnostic challenge. The aim of this study was to assess whether the plasma level of N-terminal pro-brain natriureti
Externí odkaz:
https://doaj.org/article/bb8885a820874fecb8f69c3fafdcef52
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0198069 (2018)
BACKGROUND:Atrial fibrillation (AF) is a major risk factor for ischemic stroke unless treated with an anticoagulant. Detecting AF can be difficult because AF is often paroxysmal and asymptomatic. The aims of this study were to develop a screening mod
Externí odkaz:
https://doaj.org/article/02319e7204cf4141a0eb1d1debbb1d3b
Autor:
Tijn Hendrikx, Martin Sundqvist, Herbert Sandström, Carin Sahlin, Morteza Rohani, Faris Al-Khalili, Rolf Hörnsten, Anders Blomberg, Per Wester, Mårten Rosenqvist, Karl A Franklin
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171575 (2017)
STUDY OBJECTIVES:Obstructive sleep apnea is common among patients with atrial fibrillation, but the prevalence and risk factors for atrial fibrillation among patients who are being investigated on suspicion of sleep apnea are not well known. The aim
Externí odkaz:
https://doaj.org/article/ace2f02c5ce744f2b6b9c7449fbcc43b
Autor:
Stefan H. Hohnloser, Marie Linder, Aaron Jenkins, Faris Al-Khalili, Grethe S. Tell, Sigrun Halvorsen, Morten Madsen, Vera Ehrenstein, Søren Paaske Johnsen, Gunnar Gislason, Waleed Ghanima, Gerhard Sulo
Publikováno v:
Halvorsen, S, Johnsen, S P, Madsen, M, Linder, M, Sulo, G, Ghanima, W, Gislason, G, Hohnloser, S H, Jenkins, A, Al-Khalili, F, Tell, G S & Ehrenstein, V 2022, ' Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation : a scandinavian population-based cohort study ', European heart journal. Quality of care & clinical outcomes, vol. 8, no. 5, qcab048, pp. 577-587 . https://doi.org/10.1093/ehjqcco/qcab048
Halvorsen, S, Johnsen, S P, Madsen, M, Linder, M, Sulo, G, Ghanima, W, Gislason, G, Hohnloser, S H, Jenkins, A, Al-Khalili, F, Tell, G S & Ehrenstein, V 2022, ' Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation : a Scandinavian population-based cohort study ', European Heart Journal-Quality of Care and Clinical Outcomes, vol. 8, no. 5, pp. 577-587 . https://doi.org/10.1093/ehjqcco/qcab048
qcab048
European Heart Journal-Quality of Care and Clinical Outcomes
European Heart Journal
Halvorsen, S, Johnsen, S P, Madsen, M, Linder, M, Sulo, G, Ghanima, W, Gislason, G, Hohnloser, S H, Jenkins, A, Al-Khalili, F, Tell, G S & Ehrenstein, V 2022, ' Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation : a Scandinavian population-based cohort study ', European Heart Journal-Quality of Care and Clinical Outcomes, vol. 8, no. 5, pp. 577-587 . https://doi.org/10.1093/ehjqcco/qcab048
qcab048
European Heart Journal-Quality of Care and Clinical Outcomes
European Heart Journal
Aims Using Scandinavian population-based registries, we assessed risk of stroke/systemic embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared with warfarin in anticoagulation-naïve patients with atrial fibrillation (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103794b1b53b1d203c6fb8772644bef0
https://vbn.aau.dk/ws/files/490077219/qcab048.pdf
https://vbn.aau.dk/ws/files/490077219/qcab048.pdf
Publikováno v:
Scandinavian cardiovascular journal : SCJ. 56(1)
Objectives The aim of this study was to estimate the cost-effectiveness of intermittent electrocardiogram (ECG) screening for atrial fibrillation (AF) among 70-74-year old individuals in primary care. We also aimed to assess adherence to anticoagulan
Autor:
Leif Friberg, Emma Svennberg, Faris Al-Khalili, Tove Fredriksson, Viveka Frykman, Katrin Kemp Gudmundsdottir, Johan Engdahl
Publikováno v:
Clinical Cardiology
Background There are many atrial fibrillation (AF) screening devices available. Validation studies have mainly been performed in optimal settings in the young population. Hypothesis We aim to compare the yield of AF detection, compliance, and patient
Autor:
Johan Lyth, Emma Svennberg, Lars Bernfort, Mattias Aronsson, Viveka Frykman, Faris Al-Khalili, Leif Friberg, Mårten Rosenqvist, Johan Engdahl, Lars-Åke Levin
Publikováno v:
European heart journal.
Aims Previous studies on the cost-effectiveness of screening for atrial fibrillation (AF) are based on assumptions of long-term clinical effects. The STROKESTOP study, which randomised 27 975 persons aged 75/76 years into a screening invitation group